Industry News

Covidien moving 100 jobs from Boulder to Indiana
Ocugen Receives Orphan Designation for OCU100 to Treat Retinitis Pigmentosa Ocugen, Inc.
Shire To Conduct Studies Of Vyvanse For ADHD In Children Aged 4 And 5
Shire To Conduct Studies Of Vyvanse For ADHD In Children Aged 4 And 5
FDA approves Bayer's Gadavist Injection as the first magnetic resonance contrast agent for evaluation of breast cancer in the United States
FDA approves Bayer's Gadavist (gadobutrol) Injection as the first magnetic resonance contrast agent for evaluation of breast cancer in the United States - Gadavist-enhanced breast MRI demonstrated superior sensitivity (range: 80-89%) for the
FDA Approves ALOX to Prevent Nausea and Vomiting due to Chemotherapy in Children
Teva Received FDA Approval for QVAR with Dose Counter Asthma
Covidien Neurovascular Micro Catheter Receives FDA Approval
Merck Serono Announces FDA Clearance for Auxogyn's Early Embryo Viability Assessment System
Tonix Pharmaceuticals Receives IND Clearance in PTSD Phase 2 Clinical Trial
FutureCeuticals calls for "gold-standard" clinical research on food and dietary ingredients
FutureCeuticals calls for "gold-standard" clinical research on food and dietary ingredients, but challenges FDA to properly supervise these activities under its food, not drug, authority
Tonix Pharmaceuticals Receives IND Clearance From U.S. Food and Drug Administration for TNX-102 SL in Post-Traumatic Stress Disorder Phase 2 Clinical Trial Expected to Begin in the Third Quarter of 2014
Merck Serono Announces FDA Clearance for Auxogyn's Early Embryo Viability Assessment (Eeva�) System
EU LIFTS CURBS ON DRUG EXPORT FROM RANBAXY'S TOANSA PLANT
Merck to Acquire Idenix
Merck to buy hepatitis C treatment maker Idenix Pharma for $3.85 billion in cash
Coherus BioSciences Appoints Vince R. Anicetti as Senior Vice President, Global Quality
Supplemental New Drug Application for IMBRUVICA� Accepted by the U.S. FDA and Priority Review Granted
FDA Approves Expanded Label for AZILECT� for Treatment Across All Stages of Parkinson�s Disease
Merck to Acquire Idenix
Mylan Launches Generic Paraplatin� Injection
Mylan Launches Generic Paraplatin� Injection
FDA Grants Edison Pharmaceuticals' EPI-743 Orphan Status for Leigh Syndrome EPI-743 in phase 2B development for Leigh syndrome